[1]
Bergo, I. and Pastorello, Y. 2024. Utilization of lipoxins and other specialised pro-resolving mediators in the prevention and treatment of diabetic nephropathy and diabetic cardiovascular disease. Acta Marisiensis - Seria Medica. 70, 4 (Nov. 2024). DOI:https://doi.org/10.2478/amma-2024-0037.